Vaccine update: issue 352, November 2024
Published 9 December 2024
Applies to England
© Crown copyright 2024
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/vaccine-update-issue-352-november-2024/vaccine-update-issue-352-november-2024
Flu vaccination uptake
A big thank you to all the amazing NHS flu vaccinators, including staff in general practice, pharmacy, trusts, and school age immunisation teams for all their hard work. Flu vaccination for schools has got off to an early start and is progressing well and for most adults the start date was later this year, from 3 October. This is because of the evidence about waning vaccine protection in adults which means that it is better to vaccinate closer to when flu circulates. Throughout October there has been tremendous catch-up vaccination activity in those groups which had a later vaccination start date (the older age groups and those in clinical risk groups). However, week-on-week, vaccination activity levels slowed notably at the start of November. It’s important not to lose the momentum, so a big plea to encourage the same dedication and fantastic efforts as we head into the pre-Christmas season. The flu virus is now circulating and the ‘switch-on’ of antivirals has now happened (3 December 2024), allowing the prescribing of antivirals in primary care. More information can be found on the MHRA website.
UKHSA publish a series called UKHSA Virus Watch each week on their social channels, which highlights the story behind the data in our weekly disease surveillance report for respiratory viruses. This includes static graphs each week and a fortnightly 60 second video which has a presenter explaining the data with additional context and calls to action. You can find these and UKHSA’s other content on winter vaccines on the UKHSA channels X, Facebook, Instagram, LinkedIn.
To keep up to date with the latest weekly disease surveillance data for respiratory viruses, see the link to the report published by UKHSA.
Provisional monthly data for the period of 1 September to 31 October 2024 was published on the 28 November on the flu collections page on GOV.UK.
Supplies of flu vaccines for those aged 65 years and over
Providers are reminded that every effort must be made to comply with the Joint Committee on Vaccination and Immunisation (JCVI) advice in relation to first line flu vaccination for specific age cohorts. The adjuvanted quadrivalent influenza vaccine (aQIV) and the high-dose quadrivalent influenza vaccine (QIV-HD) are recommended for use in those aged 65 years and over. QIV-HD vaccine is still available to order via Sanofi. To place an order please contact Sanofi on 0800 854 430 (select option one). Information regarding reimbursable vaccines for 2024 to 2025 can be found in the annual flu letter.
Recent change to license age for the adjuvanted quadrivalent influenza vaccine (aQIV)
Please note that on 12 September 2024 aQIV has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to be licensed from age 50 years and over. This means that those who are 64 years old turning 65 by the 31 March 2025 (and therefore eligible for flu vaccination) no longer have to be offered the vaccine ‘off-label’ as this will now be within the terms of the license. The Influenza chapter of the Green Book will be updated to reflect this new license age. However, for this year providers should follow the 2024 to 2025 annual flu letter reimbursement advice and the written instructions of the existing PGD. This means that the vaccine will not be reimbursed if offered to anyone outside of the older age cohort during the 2024 to 2025 season and can only be given under a PSD.
Public facing resources to support flu vaccination
Leaflets remain an effective way of communicating the benefits of having a flu vaccine and inform the consent process. Our leaflets and resources are all available to download and many can also be ordered for free. We have a wide range of leaflets in translated versions, simple text, large print, Braille, audio, British Sign Language (BSL) versions, and easy read and video for those who have a learning disability. For further information on the available resources and how to order them please look at our Vaccine Update Flu Special.
UKHSA has prepared a series of stakeholder communications toolkits aimed at supporting partners to raise awareness of priority campaigns, outbreak management response and health protection messaging. These provide key messages, social media assets, links to health publications and information on data and surveillance. The toolkits are available on a range of areas including winter vaccines, maternal vaccines, RSV, measles and TB. For further information please email externalaffairs@ukhsa.gov.uk
Updated publications
These vaccines help to protect you, your baby and your pregnancy
This leaflet provides updated information on the vaccines available to all pregnant women, including timings, side effects and dosage schedule for all the relevant vaccines, such as whooping cough (pertussis), RSV and MMR. This has been updated to include the latest immunisation schedule for 2024 and provides a useful record card for keeping track of all your doses. These are available to order and download for free from the health publications website, product code: 24PYPB01EN.
A guide to immunisations at one year of age
This updated leaflet provides information on the 4 vaccines children will get at their one-year vaccination visit. This details the MMR, Meningitis B, Pneumococcal and Hib/Men C vaccinations. This is available to order and download for free from the health publications website, product code: 2024QG1EN. Translations and accessible versions are also available to order and download for free.
Guide to immunisations for pre-school aged children
This leaflet details the vaccinations available to children aged 2 years old until they start pre-school. This includes information on the yearly flu vaccine, MMR and dTaP/IPV vaccines. This is available to download and order for free from the health publications website, product code: C24PSIM1EN.
A guide to the COVID-19 autumn vaccination translations and accessible versions
This leaflet contains updated information on the autumn 2024 vaccination programme for COVID-19. It explains who is being offered COVID-19, vaccination this autumn, the timing of vaccination and which vaccine will be offered. Translated and accessible versions are now available to download and order for free.
Shingles vaccination guide
The shingles leaflet has been updated to reflect the removal of Zostavax from the schedule and the use of Shingrix only. This leaflet contains information on shingles, effectiveness of the vaccine, eligibility and side effects. This is available to order and download for free from the health publications website, product code: C24SGX1EN. Accessible and translated versions will be available soon.
Publications roadshow
The publications team have been all over the country this year showing off our wonderful immunisation resources and answering questions on vaccinations and publications. As the year gets to a close we only have a couple of events left so there’s still time to come and say hello. It is a great opportunity to reflect these so see below some of the highlights of the year.
Pulse Live and Nursing in Practice
The publications and nursing teams attended the Pulse Live and Nursing in Practice conferences in the Arena and Convention Centre (ACC) in Liverpool. This were events aimed at GPs and practice nurses. General practice plays a hugely important role in vaccination and so our aim was to promote our materials and answer any questions on the delivery of vaccination. It was a fascinating opportunity to talk to health professionals we engage with on an irregular basis and to learn some new insights into how they deliver vaccination and how to increase vaccination update in harder to reach communities. Ultimately great events with many interesting conversations held.
Upcoming events
iHV Leadership Conference 2024
On 4 December 2024 the team will be attending the iHV conference in London. This is aimed at health visitors and the team will be attending the conference to promote the immunisation publications to staff which they can use in their role. The publications and nursing team will be available to answer any questions on vaccination or publications.
Vaccine supply
Routine vaccination
Attention all ImmForm customers: Christmas 2024 and New Year 2025 deliveries
Due to the Christmas and New Year Bank Holidays, there will be no deliveries or order processing by Movianto UK on Wednesday 25 and Thursday 26 December 2024, or on Wednesday 1 January 2025. See the table below for your revised order and delivery days, and the additional information for COVID-19 vaccine and offshore customers.
All customers with a standard delivery day of Wednesday, please be aware that after Wednesday 18 December 2024, your next delivery day will be Wednesday 8 January 2025.
All customers should prepare for the break in deliveries and order accordingly. Ensure you have enough room in your fridge for any additional vaccine that you order in advance of this holiday period, bearing in mind the recommendation that only 2 to 4 weeks of vaccine stock should be held locally.
Please be advised that no emergency or out of schedule deliveries can be arranged for ImmForm customers who fail to place their orders in good time.
Christmas and New Year Bank Holidays: Wednesday 25, Thursday 26 December 2024 and Wednesday 1 January 2025
| Standard delivery date | Order cut-off date | Order cut-off time | Notes/holidays |
|---|---|---|---|
| Monday 16 December 2024 | Thursday 12 December 2024 | 11:55am | N/A |
| Tuesday 17 December 2024 | Friday 13 December 2024 | 11:55am | N/A |
| Wednesday 18 December 2024 | Monday 16 December 2024 | 11:55am | Next Wednesday delivery is 8 January |
| Thursday 19 December 2024 | Tuesday 17 December 2024 | 11:55am | Next Thursday delivery is 2 January |
| Friday 20 December 2024 | Wednesday 18 December 2024 | 11:55am | N/A |
| Monday 23 December 2024 | Thursday 19 December 2024 | 11:55am | N/A |
| Tuesday 24 December 2024 | Friday 20 December 2024 | 11:55am | N/A |
| Wednesday 25 December 2024 | Christmas Day | Closed | No deliveries or order processing |
| Wednesday 26 December 2024 | Boxing Day | Closed | No deliveries or order processing |
| Friday 27 December 2024 | Monday 23 December 2024 | 11:55am | No frozen COVID vaccine will be delivered today |
| Monday 30 December 2024 | Tuesday 24 December 2024 | 11:55am | N/A |
| Tuesday 31 December 2024 | Friday 27 December 2024 | 11:55am | N/A |
| Wednesday 1 January 2025 | New Year’s Day | Closed | No deliveries or order processing |
| Thursday 2 January 2025 | Monday 30 December 2024 | 11:55am | Scotland orders delivered on 3 January No frozen COVID vaccine will be delivered today |
| Friday 3 January 2025 | Tuesday 31 December 2024 | 11:55am | N/A |
| Monday 6 January 2025 | Thursday 2 January 2025 | 11:55am | N/A |
| Tuesday 7 January 2025 | Friday 3 January 2025 | 11:55am | N/A |
| Wednesday 8 January 2025 | Monday 6 January 2025 | 11:55am | N/A |
| Thursday 9 January 2025 | Tuesday 7 January 2025 | 11:55am | N/A |
COVID-19 vaccine customers:
- frozen vaccine will not be delivered on either Friday 27 December or Thursday 2 January – only thawed vaccine will be delivered on those days
Offshore customers:
- Isle of Wight: see the table above for your revised order and delivery days
- Isle of Man: see the table above for your revised order and delivery days
- Jersey: no deliveries will be made to Jersey after Friday 20 December 2024 until Tuesday 7 January 2025 - see the table above for your revised order and delivery days
- Guernsey: no deliveries will be made to Guernsey after Friday 20 December 2024 until Tuesday 7 January 2025 - see the table above for your revised order and delivery days
- Shetland, Stornoway and Orkney: no deliveries will be made to Shetland, Stornoway or Orkney after Friday 20 December 2024 until Tuesday 7 January 2025 (orders for delivery on Tuesday 7 January 2025 have an earlier order cut-off time and date of 11:55am on Tuesday 31 December 2024)
Change of vaccine brand for meningococcal groups A, C, W and Y (MenACWY) vaccination
The vaccine brand used for meningococcal groups A, C, W and Y (MenACWY) vaccination is changing from Nimenrix® to MenQuadfi®. The vaccines are clinically equivalent. Please continue to order and administer Nimenrix® until ImmForm and local stockholdings deplete.
MenQuadfi® vaccine is now available to order via ImmForm. High-level ordering controls will be in place to reduce the risk of ordering errors only. These are not intended to restrict activity.
MenQuadfi® vaccine ordered via ImmForm is supplied as a single dose pack, containing one vial of vaccine and a patient information leaflet (PIL). The pack does not contain a needle or a syringe for administration. Guidance on the choice of needle size can be found in the chapter 22 of the Green Book. Needles and syringes should be obtained locally.
MenQuadfi® and Nimenrix® vaccines and are packed in different sized cartons. Please ensure you have enough fridge capacity before placing any orders. To help with planning storage requirements, the dimensions are:
- MenQuadfi® is 58 x 32 x 45mm (H x W x D)
- Nimenrix® was 57 x 27 x 135mm (H x W x D)
Please add MenQuadfi® to your routine ImmForm order where possible, rather than creating additional orders.
To minimise wastage due to fridge failures, please order no more than 2 weeks’ worth of stock.
Details about the meningococcal vaccination programme is published in chapter 22 of the Green Book.
Further details about MenQuadfi® vaccine can be found in the PIL. Contact the helpdesk@immform.org.uk for ordering queries.
Introduction of Abrysvo® RSV vaccine for older adults and during pregnancy for infant protection
From 1 September 2024, RSV (respiratory syncytial virus) programmes were introduced for older adults and during pregnancy for infant protection. Please refer to this publication for full details.
The same RSV vaccine, Abrysvo®, is used for both programmes.
Abrysvo® vaccine is now available to order via ImmForm. Scottish customers should refer to local ordering guidance. High-level ordering controls are in place to reduce the risk of ordering errors only. These are not intended to restrict activity. Any further updates to ordering information will be published online as an ImmForm news article.
Abrysvo® vaccine ordered via ImmForm is supplied as a single dose pack, containing one vial of vaccine, diluent for reconstitution and PIL.
Each pack also contains one 25G x 25mm (1”) needle. Guidance on the choice of needle size can be found in the Green Book chapter 4. If required, other sizes of needles should be obtained locally.
The pack of Abrysvo® vaccine is physically larger than most other vaccines supplied via ImmForm. The vaccine must be stored between 2 and 8˚C. Please ensure you have enough fridge capacity before placing any orders. To help with planning storage requirements, each single dose pack measures 73mm x 35mm x 116mm (H x W x D).
When ordering Abrysvo® vaccine, orders should be placed for the ImmForm product that is specific to each RSV protection programme.
Product ordered for the infant RSV protection programme (offered to pregnant women) should not be used for the older adult RSV protection programme and vice versa. Account holders will see 2 different product lines and should order accordingly, as shown below.
To minimise wastage due to fridge failures, please order no more than 2 weeks’ worth of stock.
Details about the RSV vaccination programmes is published in the Green Book chapter 27a.
Further details about Abrysvo® vaccine can be found in the PIL.
Contact the helpdesk@immform.org.uk for ordering queries.
Vaccines for the 2024 to 2025 children’s flu programme supplied by UKHSA
All flu vaccines for the 2024 to 2025 children’s flu programme are available to order by NHS providers in England via ImmForm.
UKHSA does not supply any flu vaccines for patients aged 18 years and over.
Please refer to guidance from your respective health departments for arrangements in Scotland, Wales and Northern Ireland.
Expiry dates for all batches of Fluenz® issued for the 2024 to 2025 children’s flu programme
Batch numbers and associated expiry dates of all batches of Fluenz® that either have or will be issued this season are set out in the table below. Please ensure that the expiry date is always checked before use and that expired stock is disposed of in line with local policies. Any disposed stock should be recorded through the ImmForm stock incident page.
| Batch number | Expiry date | Batch number | Expiry date |
|---|---|---|---|
| WH2527 | Tuesday 10 December 2024 | WK3406 | Monday 13 January 2025 |
| WH2527B | Tuesday 10 December 2024 | WK3410 | Monday 13 January 2025 |
| WH2544 | Wednesday 11 December 2024 | WL2038 | Monday 20 January 2025 |
| WH2544B | Wednesday 11 December 2024 | WL2038B | Monday 20 January 2025 |
| WH2545B | Monday 16 December 2024 | WL2039 | Monday 27 January 2025 |
| WH2546B | Tuesday 17 December 2024 | WL2039B | Monday 27 January 2025 |
| WH2547 | Wednesday 18 December 2024 | WL2041 | Tuesday 28 January 2025 |
| WH2547B | Monday 23 December 2024 | WL2040 | Monday 03 February 2025 |
| WJ2622B | Monday 23 December 2024 | WL2040B | Monday 03 February 2025 |
| WJ2150 | Tuesday 24 December 2024 | WL2522 | Monday 10 February 2025 |
| WJ2622 | Tuesday 24 December 2024 | WL2522B | Monday 10 February 2025 |
| WJ2623 | Monday 30 December 2024 | WL2688 | Monday 17 February 2025 |
| WK2074 | Monday 30 December 2024 | WL2688B | Monday 17 February 2025 |
| WK2074B | Tuesday 31 December 2024 | WM2017 | Monday 03 March 2025 |
| WK2077 | Monday 06 January 2025 |
Vaccines and availability
The 2 vaccines that are available, and the groups that these vaccines should be ordered for, are set out in the table below.
The latest and most accurate information on availability of centrally supplied vaccines for the children’s flu programme is available on the ImmForm news page at all times. It is strongly advised that all parties involved in the provision of influenza vaccines to children ensure they remain up to date with this.
| Vaccine | Manufacturer | Available to order for |
|---|---|---|
| Fluenz® (LAIV) | AstraZeneca | all children from 2 years of age to school year 11, and children in clinical risk groups aged 2 to <18 years [note 1] |
| Cell Based Quadrivalent Influenza Vaccine (Surface Antigen, Inactivated) (QIVc) | Seqirus | children in clinical risk groups aged 6 months to <2 years, and all other eligible [note 2] children aged 2 to <18 years for whom LAIV is unsuitable |
Note 1: unless LAIV clinically contraindicated or otherwise unsuitable.
Note 2: children from 2 years of age to school year 11, and children in clinical risk groups aged 2 to <18 years.
LAIV ordering information for General Practice
Ordering controls are in place for general practices, to enable UKHSA to balance supply with demand. These controls work by allocating an amount of LAIV based on the number of registered eligible patients and are tailored to each practice. GPs are able to place one order and receive one delivery of LAIV per week:
- at this time GP practices have now been allocated sufficient LAIV to vaccinate up to last year’s individual uptake achieved, or up to 45% of their eligible patients (all 2 and 3 year olds, plus children in clinical risk groups from age 4 to <18 years) if individual uptake was lower
- changes to these allocations may be made in response to demand and vaccine availability
- requests for extra vaccine will be considered on a case-by-case basis throughout the ordering period - requests for additional vaccine should be sent to the helpdesk helpdesk@immform.org.uk and should be sent in good time before your order cut-off (out of schedule deliveries will be by exception only)
LAIV ordering information for school-age providers
School providers are able to place 2 orders and receive 2 deliveries of LAIV per week, to assist in the management of vaccine volumes required across limited storage space at delivery points.
This operates on a 48-hour delivery schedule requiring the order to be placed before the 11.55am cut-off 2 working days before the required delivery day. The table below illustrates the respective delivery days versus ordering days.
Please note the bank holiday schedule when placing orders for delivery over the Christmas period.
| Order day (before 11:55am cut-off) | Delivery day |
|---|---|
| Monday | Wednesday |
| Tuesday | Thursday |
| Wednesday | Friday |
| Thursday | Monday |
| Friday | Tuesday |
Customers must ensure that the point of delivery will be open and staffed between 9am and 5pm on the delivery day when placing orders.
Please note that this 48-hour delivery schedule does not affect the routine ordering and delivery schedule of any other vaccines (including inactivated flu vaccines) ordered from ImmForm and is applicable to Fluenz® (LAIV) only.
A default weekly ordering cap of 450 packs (4,500 doses) per week is in place for school provider accounts.
Where this cap is insufficient and a provider needs a larger weekly volume of vaccine to deliver the programme (for example where a provider covers a large area using a single account), a higher weekly cap should be requested via the UKHSA Flu Vaccine Operations team by emailing childfluvaccine@ukhsa.gov.uk.
For one-off larger orders during the ordering period, requests should be made via helpdesk@immform.org.uk.
Inactivated flu vaccine ordering
The Cell Based Quadrivalent Influenza Vaccine (Surface Antigen, Inactivated) (QIVc) is available to order, in a single dose pack, for:
- children in clinical risk groups aged from six months to less than 2 years old
- children aged from 2 to <18 years old in clinical risk groups for whom LAIV is clinically contraindicated or otherwise unsuitable
- healthy children from 2 years old to those in school year 11, for whom LAIV is unsuitable (for example, due to objection to LAIV on the grounds of its porcine gelatine content)
Order controls are also in place for this vaccine as follows:
- for GPs, there is a cap of 10 doses/packs per week
- for school-age providers, there is a cap of 450 doses/packs per week
All influenza vaccines for the 2024 to 2025 season
Information on all influenza vaccines that have been marketed in the UK for the 2024 to 2025 season are available in the flu collection on GOV.UK.
The impact of changes to opening hours on routine vaccine deliveries
Please consider temporary changes to opening times when placing ImmForm orders. If you are aware of a scheduled site closure, please refrain from placing an order for that date. In case of a one-off closure, consider rescheduling your order for the week before or after. This approach will contribute to improved overall efficiencies and enhance delivery performance for the benefit of all customers.
It is not possible to accommodate one-off changes to delivery days. Customers should report long-term changes to the days and times when they can accept deliveries, such as routine training days and closures, by contacting Movianto UK Customer Care (MoviantoUK.NHSCC@movianto.com; 01234 587207). This should not be used to report short-term changes due to absence or holidays.
DTaP/IPV/Hib/HepB vaccine ordering
Supplies of DTaP/IPV/Hib/HepB vaccines Infanrix hexa® and Vaxelis® are available for the routine infant primary immunisations programme.
Orders for Infanrix hexa® remain unrestricted. Customers in England and Wales may order up to 20 packs of Vaxelis® per ImmForm account per week. Customers in Scotland should refer to their local ordering restrictions. Providers should not order more than two weeks’ worth of stock to minimise wastage due to fridge failures. For assistance, please contact the ImmForm Helpdesk at helpdesk@immform.org.uk.
The European Union (EU) Falsified Medicines Directive (FMD) will not apply in Northern Ireland from 1 January 2025
From 1 January 2025, the European Union (EU) Falsified Medicines Directive (FMD) will no longer apply in Northern Ireland. The Windsor Framework agreement removes any EU FMD packaging, labelling and barcode requirements for medicines distributed in Northern Ireland.
From 1 January 2025, customers across the UK will no longer have access to the EU database to verify or decommission unique identifier (UI) codes and will be unable to scan FMD barcodes in at any stage of the supply chain.
From 1 January 2025, customers in Northern Ireland are not required, nor will they have the capability, to verify medicines using the European Medicines Verification System (EMVS SecurMed).
MMR vaccine ordering
M-M-RvaxPro vaccine should be ordered for all MMR vaccinations, unless a patient requires a porcine gelatine-free MMR vaccine. ImmForm customers in England and Wales may order M-M-RvaxPro vaccine without restriction.
In addition, ImmForm customers in England and Wales may order up to ten porcine gelatine-free Priorix vaccines per account per week.
ImmForm customers in Scotland should refer to their local ordering restrictions.
Both MMR vaccines may only be ordered for outbreak purposes when this is part of a national catch-up campaign.
PreHevBri Supply Cessation
UKHSA has received notification from Valneva that PreHevBri is no longer being marketed in the UK so will not be included in the Non-routine vaccine supply update.
Non-routine vaccine supply
Hepatitis A vaccine
Adult:
- GSK: supply of Havrix Adult PFS singles and packs of 10 are currently available
- Sanofi: Avaxim PFS singles are currently available (Avaxim packs of 10 are currently available)
- MSD: VAQTA Adult is available
Paediatric:
- GSK: supply of Havrix Paediatric singles and packs of 10 are currently available
- MSD: VAQTA Paediatric is available
- Sanofi: Avaxim Junior singles are currently available
Hepatitis B vaccine
Adult:
- GSK: Engerix B PFS singles and packs of 10 are currently available
- GSK: supply of Fendrix is currently available
- MSD: HBVAXPRO 10µg is available
- MSD: HBVAXPRO 40µg is available
- Valneva: PreHevbri is available
Paediatric:
- GSK: supplies of Engerix B Paediatric singles are currently available
- MSD: HBVAXPRO 5µg is available
Combined hepatitis A and B vaccine
- GSK: Twinrix Adult singles and packs of 10 are available
- GSK: Twinrix Paediatric is currently available
- GSK: Ambirix is available
Combined hepatitis A and typhoid vaccine
Sanofi: Viatim is now a discontinued product and no longer available for sale
Typhoid vaccine
- Sanofi: Typhim singles and packs of 10 are available
- Patientric: Vivotif is available
Rabies vaccine
- Valneva: Rabipur is currently available
- Sanofi: Verorab is currently available
Pneumococcal polysaccharide vaccine (PPV)
MSD: supply of Pneumovax 23 (PPV23) PFS is available
Pneumococcal polysaccharide conjugate vaccine (PCV)
- Pfizer: Prevenar 13 is currently available
- MSD: Vaxneuvance is currently available
Varicella zoster vaccine
- GSK: VARILRIX is currently available
- MSD: VARIVAX is available.
- MSD: ZOSTAVAX is a discontinued product
Diphtheria, tetanus and poliomyelitis (inactivated) vaccine
Sanofi: Revaxis is available
Diphtheria, tetanus, pertussis (acellular) and poliomyelitis (inactivated) vaccine
- GSK: supply of Boostrix-IPV is currently available
- Sanofi: Repevax is currently available
MMR
- MSD: MMR Vaxpro is currently available
- GSK: Priorix is currently available
Meningitis ACWY vaccine
- GSK: Menveo is currently available
- Pfizer: Nimenrix is currently available
- Sanofi: MenQuadfi is available
Yellow fever
Sanofi: Stamaril is available
Human papillomavirus vaccine
- MSD: GARDASIL has been discontinued
- MSD: Gardasil 9 is currently available
- GSK: Cervarix has been discontinued
Cholera vaccine
- Valneva: Dukoral is available
- Patientric: Vaxchora is available
Japanese encephalytis vaccine
Valneva: Ixiaro is available
Meningococcal group B vaccine
GSK: Bexsero is currently available
Diphtheria, tetanus, pertussis, Hib vaccine and poliomyelitis
GSK: Infanrix IPV+Hib is currently available
Hib and meningococcal group C combined vaccine
GSK: Menitorix is currently available
Live attenuated rotavirus vaccine
GSK: Rotarix is currently available
Herpes zoster vaccine
GSK: Shingrix is currently available
Diphtheria, tetanus and pertussis
Sanofi: Adacel is available to order without restrictions
Dengue tetravalent vaccine
Takeda: Qdenga is currently available
Respiratory syncytial virus vaccine
Pfizer: Abrysvo is currently available